CRIS Current Research Information System

ARGNANI, LISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.317
EU - Europa 4.283
AS - Asia 2.551
AF - Africa 263
SA - Sud America 25
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.447
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.293
GB - Regno Unito 984
SE - Svezia 922
CN - Cina 865
IT - Italia 825
SG - Singapore 661
VN - Vietnam 622
DE - Germania 589
IN - India 249
IE - Irlanda 197
FR - Francia 157
RU - Federazione Russa 151
UA - Ucraina 137
TG - Togo 98
ZA - Sudafrica 75
EE - Estonia 74
FI - Finlandia 62
JO - Giordania 52
CI - Costa d'Avorio 48
NG - Nigeria 35
BE - Belgio 27
ID - Indonesia 26
CA - Canada 24
CH - Svizzera 20
PL - Polonia 20
AT - Austria 19
IR - Iran 19
BG - Bulgaria 17
HK - Hong Kong 17
NL - Olanda 17
BR - Brasile 13
ES - Italia 12
HR - Croazia 11
JP - Giappone 9
LB - Libano 9
RO - Romania 9
CZ - Repubblica Ceca 7
SC - Seychelles 7
GR - Grecia 6
AU - Australia 5
IL - Israele 5
PE - Perù 5
CL - Cile 4
MY - Malesia 4
PT - Portogallo 4
LT - Lituania 3
TR - Turchia 3
UZ - Uzbekistan 3
AR - Argentina 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
EC - Ecuador 1
EU - Europa 1
KW - Kuwait 1
LI - Liechtenstein 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
Totale 13.447
Salva come PNG Salva come JPEG
Città #
Southend 881
Fairfield 744
Chandler 622
Singapore 586
Ashburn 467
Houston 444
Santa Clara 421
Woodbridge 356
Seattle 320
Wilmington 306
Princeton 280
Dong Ket 253
Ann Arbor 248
Cambridge 242
Dublin 197
Boardman 194
Bologna 136
Berlin 113
Lomé 98
Nanjing 93
Westminster 93
New York 74
Padova 73
Jinan 72
Jacksonville 69
Beijing 64
Bremen 60
Helsinki 57
Milan 55
Amman 52
San Diego 51
Abidjan 48
Shenyang 47
Rome 43
Saint Petersburg 39
Turin 37
Abeokuta 34
Dearborn 33
Hebei 32
Redmond 32
Tianjin 30
Guangzhou 29
Brussels 26
Changsha 26
Hangzhou 26
Hyderabad 26
Jiaxing 26
Jakarta 25
Nanchang 25
Zhengzhou 25
Des Moines 24
Los Angeles 23
Shanghai 23
Redwood City 22
Florence 21
Medford 20
Olalla 20
Taizhou 19
Toronto 19
Warsaw 17
Bern 16
Norwalk 16
Falls Church 15
Phoenix 15
Mülheim 14
Sofia 14
Fuzhou 13
Haikou 13
London 13
Vienna 12
Bühl 11
Catania 11
Hong Kong 11
Ningbo 11
Paris 11
Torino 11
Verona 11
Chicago 10
Chengdu 9
Parma 9
Casalecchio di Reno 8
Naples 8
San Felice sul Panaro 8
San Francisco 8
Taiyuan 8
Tokyo 8
Andover 7
Frankfurt am Main 7
Mahé 7
Modena 7
Pesaro 7
Reggio Emilia 7
São Paulo 7
Wuhan 7
Xi'an 7
Zanjan 7
Bari 6
Lanzhou 6
Mountain View 6
Prague 6
Totale 8.926
Salva come PNG Salva come JPEG
Nome #
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience 240
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years 222
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. 197
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 184
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients 182
The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience 164
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials. 156
Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome. 155
Is it really possible to cure hairy cell leukemia patients only with frontline therapy? 154
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study 153
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. 153
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma. 153
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience 151
Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients 150
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study 150
Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study 149
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study 145
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients 145
Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program 144
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients. 136
Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma. 134
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients 132
Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis 131
Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial 130
Stile di vita e obesità nell’adolescente 129
Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase 2 study of FIL ONLUS 129
Chinese Women in Italy. Menarche, Pregnancy and Maternity. 127
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: A case report and review of the literature 126
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 125
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 125
Relationships between anthropometric parameters and motor tests in young rugby players 124
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients 124
PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series 124
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies 124
Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series. 120
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma 120
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. 120
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin. 119
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). 118
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma 118
Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports. 117
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients 116
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients 116
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified. 116
The Prognostic value of tumor and microenvironment markers in classifical Hodgkin lymphoma (CHL) patients. 115
Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens. 115
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 115
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study) 115
Efficacy of idelalisib as bridge to allogeneic stem cell transplant in relapsed follicular lymphoma: a case report 114
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice 114
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report 111
Electrochemotherapy in Vulvar Cancer and Cisplatin Combined with Electroporation. Systematic Review and In Vitro Studies 111
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma. 110
Safety and Efficacy of Single-Agent Bendamustine After Failure of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin's Lymphoma: Experience With 27 Patients. 108
Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab 108
Single-Agent Lenalidomide Is Effective in the Treatment of a Heavily Pretreated and Refractory Angioimmunoblastic T-Cell Lymphoma Patient. 107
Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease 107
Hodgkin lymphoma presenting with paraneoplastic myasthenia: a case report 107
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients 107
Growth of Chinese Italian Infants in the first 2 years of life. 106
Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. 106
The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study 105
Impressive Response to Pixantrone after Allogeneic Transplant in a Multiple Relapsed Diffuse Large B-Cell Lymphoma 105
Body image patterns, self awareness and physical growth. Preliminary notes 104
Outpatient experience with biosimilar filgrastim in patients with lymphoid neoplasm: Lessons from daily clinical practice 104
Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients. 103
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program 101
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results 101
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma 101
Primary ocular adnexal lymphomas: a retrospective study of 25 patients. 100
The prognostic value of biologic markers in classical hodgkin lymphoma (CHL) patients. 100
Weight status and body image perception in Italian children. 99
Interesting activity of pegylated liposomal doxorubicin in primary refractory and multirelapsed Hodgkin lymphoma patients: Bridge to transplant 97
Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience 96
Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental finding 96
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor 94
Hairy cell leukemia: evaluation of the long-term outcome in 121 patients. 94
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients 91
Primary Bone Lymphoma: Evaluation odf Chemoimmunotherapy as Front-line Treatment in 21 Patients 90
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice. 89
Body image and growth in Italy. 89
Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report 89
Impressive continuous complete response after mogamulizumab in a heavily pretreated Sézary syndrome patient 89
Role of autologous stem cell transplantation in T-cell lymphoma patients: a single institution retrospective analysis 88
Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients. 87
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 87
Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease 86
Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients. 85
Fat Patterning in Italian and Spanish School-children 84
Valutazione longitudinale dell’accrescimento somatico e motorio. 82
Reporting real-life experience with drugs in lymphoma patients 82
Sovrappeso ed obesità nell’adolescente bolognese: influenza dello stile di vita 81
Local versus systemic treatment for primary cutaneous B-Cell lymphoma 78
Body image perception in North Italians from childhood to adulthood . 78
Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma 78
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience 78
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 77
Pet/CT-Guided Biopsy for the diagnosis of Lymphoma 76
Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma 73
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report 71
Totale 11.631
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.196
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.667 0 0 0 0 0 0 341 380 434 205 132 175
2020/20211.764 272 96 52 46 46 61 12 74 207 73 94 731
2021/20222.408 211 81 142 249 207 114 46 189 80 178 508 403
2022/20232.856 278 417 189 380 218 214 82 226 433 94 182 143
2023/2024927 86 165 77 111 73 117 63 44 30 73 37 51
2024/20252.135 164 510 352 269 652 183 5 0 0 0 0 0
Totale 13.827